-
EP2057151
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2057151
| EP2057151 - PROCESS FOR PURIFICATION OF APREPITANT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.07.2013 Database last updated on 12.11.2024 | Most recent event Tooltip | 26.07.2013 | Application deemed to be withdrawn | published on 28.08.2013 [2013/35] | Applicant(s) | For all designated states Hetero Drugs Limited Hetero House 8-3-166/7/1, Erragadda Hyderabad, Andhrapradesh. Hyderabad 500 018 / IN | [2009/20] | Inventor(s) | 01 /
PARTHASARADHI, Reddy, Bandi Hetero House, 8-3-166/7/1, Erragadda Hyderabad, Andhrapradesh Hyderabad 500018 / IN | 02 /
RATHNAKAR REDDY, Kura Hetero Drugs Limited (R & D) Plot No. B-80 & 81, A.P.I.E., Balanagar, Hyderabad Andhrapradesh. Hyderabad 500 018 / IN | 03 /
RAJI REDDY, Rapolu Hetero Drugs Limited (R & D) Plot No. B-80 & 81, A.P.I.E., Balanagar, Hyderabad Andhrapradesh. Hyderabad 500 018 / IN | 04 /
MURALIDHARA REDDY, Dasari Hetero Drugs Limited (R & D) Plot No. B-80 & 81, A.P.I.E., Balanagar, Hyderabad Andhrapradesh. Hyderabad 500 018 / IN | 05 /
SRINIVASA RAO, Thungathurthy Hetero House, 8-3-166/7/1, Erragadda, Hyderabad, Andhrapradesh 500018 Hyderabad / IN | [2009/20] | Representative(s) | Thomas, Simon, et al Urquhart-Dykes & Lord LLP 3rd Floor 33 Glasshouse Street London W1B 5DG / GB | [N/P] |
| Former [2009/20] | Thomas, Simon, et al Urquhart-Dykes & Lord LLP 30 Welbeck Street London W1G 8ER / GB | Application number, filing date | 06796191.2 | 28.08.2006 | [2009/20] | WO2006IN00312 | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008026216 | Date: | 06.03.2008 | Language: | EN | [2008/10] | Type: | A2 Application without search report | No.: | EP2057151 | Date: | 13.05.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.03.2008 takes the place of the publication of the European patent application. | [2009/20] | Search report(s) | International search report - published on: | AT | 11.02.2010 | (Supplementary) European search report - dispatched on: | EP | 21.06.2010 | Classification | IPC: | C07D413/06 | [2009/20] | CPC: |
C07D413/06 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2009/20] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | VERFAHREN ZUR REINIGUNG VON APREPITANT | [2009/20] | English: | PROCESS FOR PURIFICATION OF APREPITANT | [2009/20] | French: | PROCÉDÉ DE PURIFICATION D'APRÉPITANT | [2009/20] | Entry into regional phase | 28.11.2007 | National basic fee paid | 28.11.2007 | Search fee paid | 27.11.2007 | Designation fee(s) paid | 28.11.2007 | Examination fee paid | Examination procedure | 28.11.2007 | Examination requested [2009/20] | 14.01.2011 | Amendment by applicant (claims and/or description) | 14.04.2011 | Despatch of a communication from the examining division (Time limit: M06) | 06.02.2012 | Reply to a communication from the examining division | 01.03.2013 | Application deemed to be withdrawn, date of legal effect [2013/35] | 09.04.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/35] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 14.04.2011 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 06.02.2012 | Request for further processing filed | 06.02.2012 | Full payment received (date of receipt of payment) Request granted | 20.02.2012 | Decision despatched | Fees paid | Renewal fee | 13.06.2008 | Renewal fee patent year 03 | 26.08.2009 | Renewal fee patent year 04 | 13.08.2010 | Renewal fee patent year 05 | 27.07.2011 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.08.2012 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO03089429 (MERCK & CO INC [US], et al) [A] 1-30 * page 7, line 20 - line 22 * | International search | [A]WO9516679 (MERCK & CO., INC); | [X]WO9901444 (MERCK& CO., INC); | [X]US6096742 (CROCKER LOUIS ET AL); | [E]WO2007039883 (RANBAXY LABORATORIES LIMITED); | [XP]WO2007016582 (REDDYS LAB LTD); | [X]US2004214746 (W. BOSCH,E. LIVERSIDGE, D SUHAS, K.THOMPSON) | [X] - HALE J ET AL., "'' Structural optimalization affording 2-R-(1 R-3,5- bis/trifluormethyl)phenylethoxy)-3-S-(4-florophenyl-4-(3-oxo- 1,2,4.triazol-5-yl)methylmorpholine, a potent, orally active, long- acting porpholine acetal human NK-1 receptor antagonist)", J. MED. CHEM, (1998), vol. 41, pages 4607 - 4614, XP002265195 DOI: http://dx.doi.org/10.1021/jm980299k |